{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:24:34Z","timestamp":1778718274831,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2012,1,13]],"date-time":"2012-01-13T00:00:00Z","timestamp":1326412800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1038\/cdd.2011.209","type":"journal-article","created":{"date-parts":[[2012,1,13]],"date-time":"2012-01-13T10:20:56Z","timestamp":1326450056000},"page":"1196-1207","source":"Crossref","is-referenced-by-count":32,"title":["Regulation in the targeting of TRAIL receptor 1 to cell surface via GODZ for TRAIL sensitivity in tumor cells"],"prefix":"10.1038","volume":"19","author":[{"given":"Y","family":"Oh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y-J","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G-S","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H-N","family":"Woo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y-K","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,1,13]]},"reference":[{"key":"BFcdd2011209_CR1","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1126\/science.281.5381.1305","volume":"281","author":"A Ashkenazi","year":"1998","unstructured":"Ashkenazi A, Dixit VM . Death receptors: signaling and modulation. Science 1998; 281: 1305\u20131308.","journal-title":"Science"},{"key":"BFcdd2011209_CR2","first-page":"335","volume":"6","author":"K Kim","year":"2000","unstructured":"Kim K, Fisher MJ, Xu SQ, el-Deiry WS . Molecular determinants of response to TRAIL in killing of normal and cancer cells. Clin Cancer Res 2000; 6: 335\u2013346.","journal-title":"Clin Cancer Res"},{"key":"BFcdd2011209_CR3","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1101\/gad.1063703","volume":"17","author":"L Salmena","year":"2003","unstructured":"Salmena L, Lemmers B, Hakem A, Matysiak-Zablocki E, Murakami K, Au PY et al. Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity. Genes Dev 2003; 17: 883\u2013895.","journal-title":"Genes Dev"},{"key":"BFcdd2011209_CR4","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1006\/bbrc.2000.3673","volume":"277","author":"IK Kim","year":"2000","unstructured":"Kim IK, Chung CW, Woo HN, Hong GS, Nagata S, Jung YK . Reconstitution of caspase-8 sensitizes JB6 cells to TRAIL. Biochem Biophys Res Commun 2000; 277: 311\u2013316.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFcdd2011209_CR5","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S1074-7613(00)80212-5","volume":"12","author":"FC Kischkel","year":"2000","unstructured":"Kischkel FC, Lawrence DA, Chuntharapai A, Schow P, Kim KJ, Ashkenazi A . Apo2L\/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity 2000; 12: 611\u2013620.","journal-title":"Immunity"},{"key":"BFcdd2011209_CR6","doi-asserted-by":"publisher","first-page":"6638","DOI":"10.1128\/MCB.20.18.6638-6645.2000","volume":"20","author":"Y Lin","year":"2000","unstructured":"Lin Y, Devin A, Cook A, Keane MM, Kelliher M, Lipkowitz S et al. The death domain kinase RIP is essential for TRAIL (Apo2L)-induced activation of IkappaB kinase and c-Jun N-terminal kinase. Mol Cell Biol 2000; 20: 6638\u20136645.","journal-title":"Mol Cell Biol"},{"key":"BFcdd2011209_CR7","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/S1074-7613(00)80401-X","volume":"7","author":"P Schneider","year":"1997","unstructured":"Schneider P, Thome M, Burns K, Bodmer JL, Hofmann K, Kataoka T et al. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB. Immunity 1997; 7: 831\u2013836.","journal-title":"Immunity"},{"key":"BFcdd2011209_CR8","first-page":"2770","volume":"59","author":"GS Wu","year":"1999","unstructured":"Wu GS, Burns TF, Zhan Y, Alnemri ES, El-Deiry WS . Molecular cloning and functional analysis of the mouse homologue of the KILLER\/DR5 tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor. Cancer Res 1999; 59: 2770\u20132775.","journal-title":"Cancer Res"},{"key":"BFcdd2011209_CR9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1172\/JCI29900","volume":"118","author":"N Finnberg","year":"2008","unstructured":"Finnberg N, Klein-Szanto AJ, El-Deiry WS . TRAIL-R deficiency in mice promotes susceptibility to chronic inflammation and tumorigenesis. J Clin Invest 2008; 118: 111\u2013123.","journal-title":"J Clin Invest"},{"key":"BFcdd2011209_CR10","doi-asserted-by":"publisher","first-page":"4798","DOI":"10.1038\/sj.onc.1209608","volume":"25","author":"S Fulda","year":"2006","unstructured":"Fulda S, Debatin KM . Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 2006; 25: 4798\u20134811.","journal-title":"Oncogene"},{"key":"BFcdd2011209_CR11","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/sj.cdd.4401187","volume":"10","author":"HN LeBlanc","year":"2003","unstructured":"LeBlanc HN, Ashkenazi A . Apo2L\/TRAIL and its death and decoy receptors. Cell Death Differ 2003; 10: 66\u201375.","journal-title":"Cell Death Differ"},{"key":"BFcdd2011209_CR12","doi-asserted-by":"crossref","first-page":"920","DOI":"10.4049\/jimmunol.163.2.920","volume":"163","author":"LM Sedger","year":"1999","unstructured":"Sedger LM, Shows DM, Blanton RA, Peschon JJ, Goodwin RG, Cosman D et al. IFN-gamma mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression. J Immunol 1999; 163: 920\u2013926.","journal-title":"J Immunol"},{"key":"BFcdd2011209_CR13","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.leukres.2011.03.016","volume":"35","author":"X Zhang","year":"2011","unstructured":"Zhang X, Inukai T, Akahane K, Hirose K, Kuroda I, Honna H et al. Endoplasmic reticulum stress inducers, but not imatinib, sensitize Philadelphia chromosome-positive leukemia cells to TRAIL-mediated apoptosis. Leukemia Res 2011; 35: 940\u2013949.","journal-title":"Leukemia Res"},{"key":"BFcdd2011209_CR14","doi-asserted-by":"publisher","first-page":"5078","DOI":"10.1158\/0008-5472.CAN-04-1195","volume":"64","author":"X Liu","year":"2004","unstructured":"Liu X, Yue P, Khuri FR, Sun SY . p53 upregulates death receptor 4 expression through an intronic p53 binding site. Cancer Res 2004; 64: 5078\u20135083.","journal-title":"Cancer Res"},{"key":"BFcdd2011209_CR15","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1007\/s10495-008-0210-0","volume":"13","author":"FJ Mendoza","year":"2008","unstructured":"Mendoza FJ, Ishdorj G, Hu X, Gibson SB . Death receptor-4 (DR4) expression is regulated by transcription factor NF-kappaB in response to etoposide treatment. Apoptosis 2008; 13: 756\u2013770.","journal-title":"Apoptosis"},{"key":"BFcdd2011209_CR16","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1126\/science.277.5327.818","volume":"277","author":"JP Sheridan","year":"1997","unstructured":"Sheridan JP, Marsters SA, Pitti RM, Gurney A, Skubatch M, Baldwin D et al. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 1997; 277: 818\u2013821.","journal-title":"Science"},{"key":"BFcdd2011209_CR17","doi-asserted-by":"publisher","first-page":"22320","DOI":"10.1074\/jbc.M202458200","volume":"277","author":"Y Kim","year":"2002","unstructured":"Kim Y, Suh N, Sporn M, Reed JC . An inducible pathway for degradation of FLIP protein sensitizes tumor cells to TRAIL-induced apoptosis. J Biol Chem 2002; 277: 22320\u201322329.","journal-title":"J Biol Chem"},{"key":"BFcdd2011209_CR18","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1126\/science.1098231","volume":"305","author":"L Li","year":"2004","unstructured":"Li L, Thomas RM, Suzuki H, De Brabander JK, Wang X, Harran PG . A small molecule Smac mimic potentiates TRAIL- and TNFalpha-mediated cell death. Science 2004; 305: 1471\u20131474.","journal-title":"Science"},{"key":"BFcdd2011209_CR19","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1038\/nm1627","volume":"13","author":"KW Wagner","year":"2007","unstructured":"Wagner KW, Punnoose EA, Januario T, Lawrence DA, Pitti RM, Lancaster K et al. Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L\/TRAIL. Nat Med 2007; 13: 1070\u20131077.","journal-title":"Nat Med"},{"key":"BFcdd2011209_CR20","doi-asserted-by":"publisher","first-page":"4344","DOI":"10.1038\/onc.2008.73","volume":"27","author":"YJ Jeon","year":"2008","unstructured":"Jeon YJ, Kim IK, Hong SH, Nan H, Kim HJ, Lee HJ et al. Ribosomal protein S6 is a selective mediator of TRAIL-apoptotic signaling. Oncogene 2008; 27: 4344\u20134352.","journal-title":"Oncogene"},{"key":"BFcdd2011209_CR21","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/cdd.2010.113","volume":"18","author":"H Choi","year":"2011","unstructured":"Choi H, Chang JW, Jung YK . Peroxiredoxin 6 interferes with TRAIL-induced death-inducing signaling complex formation by binding to death effector domain caspase. Cell Death Differ 2011; 18: 405\u2013414.","journal-title":"Cell Death Differ"},{"key":"BFcdd2011209_CR22","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1091\/mbc.e07-11-1164","volume":"19","author":"C Sharma","year":"2008","unstructured":"Sharma C, Yang XH, Hemler ME . DHHC2 affects palmitoylation, stability, and functions of tetraspanins CD9 and CD151. Mol Biol Cell 2008; 19: 3415\u20133425.","journal-title":"Mol Biol Cell"},{"key":"BFcdd2011209_CR23","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1074\/mcp.M800069-MCP200","volume":"7","author":"J Zhang","year":"2008","unstructured":"Zhang J, Planey SL, Ceballos C, Stevens Jr SM, Keay SK, Zacharias DA . Identification of CKAP4\/p63 as a major substrate of the palmitoyl acyltransferase DHHC2, a putative tumor suppressor, using a novel proteomics method. Mol Cell Proteomics 2008; 7: 1378\u20131388.","journal-title":"Mol Cell Proteomics"},{"key":"BFcdd2011209_CR24","doi-asserted-by":"publisher","first-page":"9230","DOI":"10.1038\/sj.onc.1208171","volume":"23","author":"CE Ducker","year":"2004","unstructured":"Ducker CE, Stettler EM, French KJ, Upson JJ, Smith CD . Huntingtin interacting protein 14 is an oncogenic human protein: palmitoyl acyltransferase. Oncogene 2004; 23: 9230\u20139237.","journal-title":"Oncogene"},{"key":"BFcdd2011209_CR25","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/S0006-291X(02)00900-2","volume":"296","author":"T Uemura","year":"2002","unstructured":"Uemura T, Mori H, Mishina M . Isolation and characterization of Golgi apparatus-specific GODZ with the DHHC zinc finger domain. Biochem Biophys Res Commun 2002; 296: 492\u2013496.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFcdd2011209_CR26","doi-asserted-by":"publisher","first-page":"5881","DOI":"10.1523\/JNEUROSCI.1037-04.2004","volume":"24","author":"CA Keller","year":"2004","unstructured":"Keller CA, Yuan X, Panzanelli P, Martin ML, Alldred M, Sassoe-Pognetto M et al. The gamma2 subunit of GABA(A) receptors is a substrate for palmitoylation by GODZ. J Neurosci 2004; 24: 5881\u20135891.","journal-title":"J Neurosci"},{"key":"BFcdd2011209_CR27","doi-asserted-by":"publisher","first-page":"12758","DOI":"10.1523\/JNEUROSCI.4214-06.2006","volume":"26","author":"C Fang","year":"2006","unstructured":"Fang C, Deng L, Keller CA, Fukata M, Fukata Y, Chen G et al. GODZ-mediated palmitoylation of GABA(A) receptors is required for normal assembly and function of GABAergic inhibitory synapses. J Neurosci 2006; 26: 12758\u201312768.","journal-title":"J Neurosci"},{"key":"BFcdd2011209_CR28","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.neuron.2005.06.035","volume":"47","author":"T Hayashi","year":"2005","unstructured":"Hayashi T, Rumbaugh G, Huganir RL . Differential regulation of AMPA receptor subunit trafficking by palmitoylation of two distinct sites. Neuron 2005; 47: 709\u2013723.","journal-title":"Neuron"},{"key":"BFcdd2011209_CR29","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/S1097-2765(02)00496-3","volume":"9","author":"CD Hu","year":"2002","unstructured":"Hu CD, Chinenov Y, Kerppola TK . Visualization of interactions among bZIP and Rel family proteins in living cells using bimolecular fluorescence complementation. Mol Cell 2002; 9: 789\u2013798.","journal-title":"Mol Cell"},{"key":"BFcdd2011209_CR30","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1042\/BJ20081212","volume":"419","author":"A Rossin","year":"2009","unstructured":"Rossin A, Derouet M, Abdel-Sater F, Hueber AO . Palmitoylation of the TRAIL receptor DR4 confers an efficient TRAIL-induced cell death signalling. Biochem J 2009; 419: 185\u2013192.","journal-title":"Biochem J"},{"key":"BFcdd2011209_CR31","doi-asserted-by":"publisher","first-page":"4621","DOI":"10.1074\/jbc.M109.069849","volume":"285","author":"RM Hines","year":"2010","unstructured":"Hines RM, Kang R, Goytain A, Quamme GA . Golgi-specific DHHC zinc finger protein GODZ mediates membrane Ca2+ transport. J Biol Chem 2010; 285: 4621\u20134628.","journal-title":"J Biol Chem"},{"key":"BFcdd2011209_CR32","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10495-007-0171-8","volume":"13","author":"S Simova","year":"2008","unstructured":"Simova S, Klima M, Cermak L, Sourkova V, Andera L . Arf and Rho GAP adapter protein ARAP1 participates in the mobilization of TRAIL-R1\/DR4 to the plasma membrane. Apoptosis 2008; 13: 423\u2013436.","journal-title":"Apoptosis"},{"key":"BFcdd2011209_CR33","doi-asserted-by":"publisher","first-page":"5064","DOI":"10.1091\/mbc.e04-03-0184","volume":"15","author":"YG Ren","year":"2004","unstructured":"Ren YG, Wagner KW, Knee DA, Aza-Blanc P, Nasoff M, Deveraux QL . Differential regulation of the TRAIL death receptors DR4 and DR5 by the signal recognition particle. Mol Biol Cell 2004; 15: 5064\u20135074.","journal-title":"Mol Biol Cell"},{"key":"BFcdd2011209_CR34","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1182\/blood.V97.9.2596","volume":"97","author":"R Di Pietro","year":"2001","unstructured":"Di Pietro R, Secchiero P, Rana R, Gibellini D, Visani G, Bemis K et al. Ionizing radiation sensitizes erythroleukemic cells but not normal erythroblasts to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)\u2013mediated cytotoxicity by selective up-regulation of TRAIL-R1. Blood 2001; 97: 2596\u20132603.","journal-title":"Blood"},{"key":"BFcdd2011209_CR35","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/sj.cdd.4401649","volume":"12","author":"M MacFarlane","year":"2005","unstructured":"MacFarlane M, Inoue S, Kohlhaas SL, Majid A, Harper N, Kennedy DB et al. Chronic lymphocytic leukemic cells exhibit apoptotic signaling via TRAIL-R1. Cell Death Differ 2005; 12: 773\u2013782.","journal-title":"Cell Death Differ"},{"key":"BFcdd2011209_CR36","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1158\/1541-7786.MCR-04-0136","volume":"3","author":"P Horak","year":"2005","unstructured":"Horak P, Pils D, Haller G, Pribill I, Roessler M, Tomek S et al. Contribution of epigenetic silencing of tumor necrosis factor-related apoptosis inducing ligand receptor 1 (DR4) to TRAIL resistance and ovarian cancer. Mol Cancer Res 2005; 3: 335\u2013343.","journal-title":"Mol Cancer Res"},{"key":"BFcdd2011209_CR37","doi-asserted-by":"publisher","first-page":"4570","DOI":"10.1016\/j.febslet.2010.10.052","volume":"584","author":"J Wang","year":"2010","unstructured":"Wang J, Xie Y, Wolff DW, Abel PW, Tu Y . DHHC protein-dependent palmitoylation protects regulator of G-protein signaling 4 from proteasome degradation. FEBS Lett 2010; 584: 4570\u20134574.","journal-title":"FEBS Lett"},{"key":"BFcdd2011209_CR38","first-page":"5683","volume":"59","author":"SH Lee","year":"1999","unstructured":"Lee SH, Shin MS, Kim HS, Lee HK, Park WS, Kim SY et al. Alterations of the DR5\/TRAIL receptor 2 gene in non-small cell lung cancers. Cancer Res 1999; 59: 5683\u20135686.","journal-title":"Cancer Res"},{"key":"BFcdd2011209_CR39","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1158\/0008-5472.CAN-06-1806","volume":"68","author":"LM Laguinge","year":"2008","unstructured":"Laguinge LM, Samara RN, Wang W, El-Deiry WS, Corner G, Augenlicht L et al. DR5 receptor mediates anoikis in human colorectal carcinoma cell lines. Cancer Res 2008; 68: 909\u2013917.","journal-title":"Cancer Res"},{"key":"BFcdd2011209_CR40","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1271\/bbb.70342","volume":"71","author":"S Nishiumi","year":"2007","unstructured":"Nishiumi S, Ashida H . Rapid preparation of a plasma membrane fraction from adipocytes and muscle cells: application to detection of translocated glucose transporter 4 on the plasma membrane. Biosci Biotechnol Biochem 2007; 71: 2343\u20132346.","journal-title":"Biosci Biotechnol Biochem"}],"container-title":["Cell Death & Differentiation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/cdd2011209.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cdd2011209","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cdd2011209.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T14:34:00Z","timestamp":1686666840000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cdd2011209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,13]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["BFcdd2011209"],"URL":"https:\/\/doi.org\/10.1038\/cdd.2011.209","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,13]]}}}